Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 12Neoplasms 7Fatigue 6Prostatic Neoplasms 5Lung Neoplasms 5Motor Activity 4Lymphedema 4Hematologic Neoplasms 4Pain 3Trismus 2Peripheral Nervous System Diseases 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Glioma 2Esophageal Neoplasms 2Cachexia 2Breast Neoplasms, Male 2Urologic Neoplasms 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Transcranial Magnetic Stimulation, Repetitive 1Thrombosis 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sleep Initiation and Maintenance Disorders 1Shoulder Pain 1Sarcoma, Synovial 1Sarcoma, Ewing 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 124Nivolumab 85pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 43Leucovorin 40tremelimumab 37camrelizumab 37Radiofrequency Ablation 37Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28cabozantinib 26Hepatectomy 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × Physical Therapy Modalities × Clear all
NCT04602026 2025-04-04

RIOT

Ohio State University Comprehensive Cancer Center

Phase NA Completed
66 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡